Immune evasion mechanisms of human papillomavirus: An update

No abstract is available for this paper.

• Publication year

  2018

• Venue

  International Journal of Cancer

• Publication date

  2018-01-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.31027PMID 28865151
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of integration in oncogenic progression of HPV-associated cancers

  2017cited by this paper
• HPV16 induces a wasting syndrome in transgenic mice: Amelioration by dietary polyphenols via NF‐&kgr;B inhibition

  2017cited by this paper
• ERAP1 overexpression in HPV-induced malignancies: A possible novel immune evasion mechanism

  2017cited by this paper
• Evasion of host immune defenses by human papillomavirus.

  2017cited by this paper
• Cyclic GMP-AMP as an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA.

  2017cited by this paper
• Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases

  2016cited by this paper
• Suppression of the CD8 T cell response by human papillomavirus type 16 E7 occurs in Langerhans cell-depleted mice

  2016cited by this paper
• Suppression of Antitumor Immune Responses by Human Papillomavirus through Epigenetic Downregulation of CXCL14

  2016influential reference
• Carcinogenic human papillomavirus infection

  2016cited by this paper
• Early Defensive Mechanisms against Human Papillomavirus Infection

  2015cited by this paper
• Tissue-based map of the human proteome

  2015cited by this paper
• Downregulation of Toll-Like Receptor 9 Expression by Beta Human Papillomavirus 38 and Implications for Cell Cycle Control

  2015influential reference
• DNA tumor virus oncogenes antagonize the cGAS-STING DNA-sensing pathway

  2015influential reference
• Human papillomavirus molecular biology and disease association

  2015cited by this paper
• Human Papillomaviruses; Epithelial Tropisms, and the Development of Neoplasia

  2015cited by this paper
• Therapeutic Vaccine Strategies against Human Papillomavirus

  2014cited by this paper
• MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells.

  2013cited by this paper
• The Human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter

  2013cited by this paper
• Cyclic GMP-AMP Is an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA

  2013cited by this paper
• Human papillomavirus and cervical cancer.

  2013cited by this paper
• Comparative expression profiling for human endoplasmic reticulum-resident aminopeptidases 1 and 2 in normal kidney versus distinct renal cell carcinoma subtypes.

  2013cited by this paper
• Global burden of human papillomavirus and related diseases.

  2012cited by this paper
• Post-Transcriptional and Epigenetic Regulation of Antigen Processing Machinery (APM) Components and HLA-I in Cervical Cancers from Uighur Women

  2012influential reference
• Role of Endoplasmic Reticulum Aminopeptidases in Health and Disease: from Infection to Cancer

  2012cited by this paper
• The Papillomavirus Episteme: a central resource for papillomavirus sequence data and analysis

  2012cited by this paper
• Epithelial Cell Responses to Infection with Human Papillomavirus

  2012cited by this paper
• Updating the natural history of human papillomavirus and anogenital cancers.

  2012cited by this paper
• Reconstruction of Human Papillomavirus Type 16-Mediated Early-Stage Neoplasia Implicates E6/E7 Deregulation and the Loss of Contact Inhibition in Neoplastic Progression

  2012cited by this paper
• Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis.

  2012cited by this paper
• HPV and Cervical Cancer

  2011cited by this paper
• Human papillomavirus infection induces NF-κB activation in cervical cancer: A comparison with penile cancer.

  2011cited by this paper
• Epigenetic repression of E-cadherin by human papillomavirus 16 E7 protein

  2010cited by this paper
• Pattern Recognition via the Toll-Like Receptor System in the Human Female Genital Tract

  2010cited by this paper
• Epigenetic silencing of interferon-kappa in human papillomavirus type 16-positive cells.

  2009cited by this paper
• Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation.

  2009cited by this paper
• HPV16 Tumor Associated Macrophages Suppress Antitumor T Cell Responses

  2009cited by this paper
• Single nucleotide polymorphisms in antigen processing machinery component ERAP1 significantly associate with clinical outcome in cervical carcinoma

  2009cited by this paper
• Papillomaviruses in the causation of human cancers - a brief historical account.

  2009cited by this paper
• Immunobiology of HPV and HPV vaccines.

  2008influential reference
• Altered expression of endoplasmic reticulum aminopeptidases ERAP1 and ERAP2 in transformed non‐lymphoid human tissues

  2008cited by this paper
• Circulating human papillomavirus type 16 specific T‐cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts

  2007cited by this paper
• Viral oncoproteins target the DNA methyltransferases

  2007cited by this paper
• TLR9 Expression and Function Is Abolished by the Cervical Cancer-Associated Human Papillomavirus Type 161

  2007cited by this paper
• Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma

  2007cited by this paper
• The E5 protein of the human papillomavirus type 16 down-regulates HLA-I surface expression in calnexin-expressing but not in calnexin-deficient cells

  2007cited by this paper
• Expression switching in the stevor and Pfmc‐2TM superfamilies in Plasmodium falciparum

  2007cited by this paper
• Chromatin modifications and their function.

  2007cited by this paper
• The Human Papillomavirus Type 16 E7 Protein Binds Human Interferon Regulatory Factor-9 via a Novel PEST Domain Required for Transformation

  2006cited by this paper
• Immune responses to human papillomavirus.

  2006cited by this paper
• Expression of Endoplasmic Reticulum Aminopeptidases in EBV-B Cell Lines from Healthy Donors and in Leukemia/Lymphoma, Carcinoma, and Melanoma Cell Lines1

  2006cited by this paper
• Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo.

  2006cited by this paper
• Chapter 1: HPV in the etiology of human cancer.

  2006cited by this paper
• Cutaneous CXCL14 targets blood precursors to epidermal niches for Langerhans cell differentiation.

  2005cited by this paper
• Immune control of human papillomavirus (HPV) associated anogenital disease and potential for vaccination.

  2005cited by this paper
• Loss of New Chemokine CXCL14 in Tumor Tissue Is Associated with Low Infiltration by Dendritic Cells (DC), while Restoration of Human CXCL14 Expression in Tumor Cells Causes Attraction of DC Both In Vitro and In Vivo1

  2005cited by this paper
• Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.

  2005cited by this paper
• E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I

  2005cited by this paper
• Increased secretion patterns of interleukin-10 and tumor necrosis factor-alpha in cervical squamous intraepithelial lesions.

  2004cited by this paper
• Human Papillomavirus and Cervical Cancer

  2003cited by this paper
• Abrogation of IRF-1 response by high-risk HPV E7 protein in vivo.

  2002cited by this paper
• Human Papillomavirus Virus-Like Particles Do Not Activate Langerhans Cells: A Possible Immune Escape Mechanism Used by Human Papillomaviruses1

  2002cited by this paper
• The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8–9 residues

  2002cited by this paper
• Antigen Processing Defects in Cervical Carcinomas Limit the Presentation of a CTL Epitope from Human Papillomavirus 16 E61

  2001influential reference
• Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.

  2000cited by this paper
• Inactivation of Interferon Regulatory Factor-1 Tumor Suppressor Protein by HPV E7 Oncoprotein

  2000cited by this paper
• Golgi Alkalinization by the Papillomavirus E5 Oncoprotein

  2000cited by this paper
• Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chain, TAP1 and LMP2 genes by the human papillomavirus (HPV) type 6b, 16 and 18 E7 oncoproteins

  2000cited by this paper
• The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-α

  1999cited by this paper
• The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha.

  1999cited by this paper
• Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 zeta chain of T-cell receptor complex and antigen-specific T-cell responses.

  1996cited by this paper
• Chromatin Modifications and Their Function

  year unknowncited by this paper

• A discrete nonlinear model for HPV immune suppression and evasion.

  2026cites this paper
• Human Papillomavirus-Induced Keratinizing Squamous Cell Carcinoma in Ovarian Cystic Teratoma: A Case Report and Literature Review

  2026cites this paper
• Observations of Wart Clearance Following COVID-19 Vaccination: Coincidence or Missed Immunologic Signals?

  2025cites this paper
• Cell-free HPV-DNA as a high-accuracy biomarker for treatment de-escalation in HPV-positive head and neck squamous cell carcinoma

  2025cites this paper
• The codon context provides cis-acting immune evasion for the human papilloma virus (HPV) E6.

  2025cites this paper
• ADAR1 expression is associated with cervical cancer progression and negatively regulates NK cell activity

  2025cites this paper
• HPV-driven inflammatory pathways in ovarian carcinogenesis: molecular mechanisms and emerging therapeutic interventions

  2025cites this paper
• The role and mechanism of human papillomavirus in urinary system tumors

  2025cites this paper
• Immune responses to human papillomavirus infection and vaccination

  2025cites this paper
• Intralesional Immunotherapy for Non-Genital Viral Warts: A Review of Current Evidence and Future Perspectives

  2025cites this paper
• Role of innate immunity in tumor microenvironment of HPV-associated anal cancer: the hypothetical beneficial role of γδ T cells.

  2025cites this paper
• The Sibylline Relationship Between Human Papillomavirus and Endometrial Cancer: Scarcity of Strong Evidence Linking Both Conditions

  2025cites this paper
• Interleukins in the Pathogenesis of Warts: Insight from the Last Decade—A Narrative Review

  2025cites this paper
• A review of the carcinogenic potential of human papillomavirus (HPV) in urological cancers

  2025cites this paper
• Molecular Insights into HR-HPV and HCMV Co-Presence in Cervical Cancer Development

  2025cites this paper
• HPV Infection and Oral Microbiota: Interactions and Future Implications

  2025cites this paper
• High-Grade Cervical Intraepithelial Neoplasia: Impact of Colposcopic Lesion Area on Systemic Immune Responses

  2025cites this paper
• Deciphering the Role of Mast Cells in HPV-Related Cancers

  2025cites this paper
• Modelling the economic effects of HPV-vaccination for adolescents of both sexes

  2025cites this paper
• HPV vaccine-related thyroid adverse events: temporal patterns and reporting trends

  2025cites this paper
• The expression and significance of PD‐L1 in condyloma acuminatum

  2024cites this paper
• Epigenetic Alterations That Are the Backbone of Immune Evasion in T-cell Malignancies

  2024cites this paper
• Combined Effects of TLR4 and HIF-1α with COX-2 Genes in Cervical Squamous Cell Carcinoma Associated with HPV Infection

  2024cites this paper
• Neoadjuvant immunotherapy and oncolytic virotherapy in HPV positive and HPV negative skin cancer: A comprehensive review.

  2024cites this paper
• Human papillomavirus infection of the fallopian tube as a potential risk factor for epithelial ovarian cancer

  2024cites this paper
• HPV-YAP1 oncogenic alliance drives malignant transformation of fallopian tube epithelial cells

  2024cites this paper
• Leveraging oncovirus-derived antigen against the viral malignancies in adoptive cell therapies

  2024cites this paper
• Comparison of preclinical efficacy of immunotherapies against HPV-induced cancers

  2024cites this paper
• Human Papillomavirus in Oral Lichen Planus: Is There an Association? A Meta-Analysis

  2024cites this paper
• High‐risk HPV oncoproteins E6 and E7 and their interplay with the innate immune response: Uncovering mechanisms of immune evasion and therapeutic prospects

  2024cites this paper
• Prevalence and Risk Factors for HPV Seropositivity and Anogenital DNA-Positivity among Men Who Have Sex With Men: A Repeated Cross-Sectional Study.

  2024cites this paper
• Emerging biomarkers and molecular targets for precision medicine in cervical cancer.

  2024cites this paper
• RETRACTED: Development of gene panel for predicting recurrence in early‐stage cervical cancer patients

  2024cites this paper
• Diagnosis and Management of Cervical Squamous Intraepithelial Lesions in Pregnancy and Postpartum.

  2024cites this paper
• Molecular aspects of cervical cancer: a pathogenesis update

  2024cites this paper
• A novel therapeutic multiepitope vaccine based on oncoprotein E6 and E7 of HPV 16 and 18: An in silico approach

  2024cites this paper
• Prevention and treatment of HPV‐related cancer through a mRNA vaccine expressing APC‐targeting antigen

  2024cites this paper
• Human Papilloma Virus Positive Oropharyngeal Squamous Cell Carcinoma and the Immune System: Pathogenesis, Immunotherapy and Future Perspectives

  2024cites this paper
• Analogies between HPV Behavior in Oral and Vaginal Cavity: Narrative Review on the Current Evidence in the Literature

  2024cites this paper
• Optimization and Validation of a Harmonized Protocol for Generating Therapeutic-Grade Dendritic Cells in a Randomized Phase II Clinical Trial, Using Two Varied Antigenic Sources

  2024cites this paper
• Retrospective Investigation of Human Papillomavirus Cervical Infection and Lymphoma Incidence: A Clinical and Pathological Evaluation

  2024cites this paper
• Detection and Genotyping of Human Papillomavirus (HPV16/18), Epstein–Barr Virus (EBV), and Human Cytomegalovirus (HCMV) in Endometrial Endometroid and Ovarian Cancers

  2023influential citation
• Epidemiology, Molecular Pathogenesis, Immuno-Pathogenesis, Immune Escape Mechanisms and Vaccine Evaluation for HPV-Associated Carcinogenesis

  2023cites this paper
• Comparative Analysis of Alpha and Beta HPV E6 Oncoproteins: Insights into Functional Distinctions and Divergent Mechanisms of Pathogenesis

  2023cites this paper
• Immunotherapy Growing Role in Warts Management: Review Article

  2023cites this paper
• HPV co‐infections with other pathogens in cancer development: A comprehensive review

  2023cites this paper
• When Bacteria and Viruses Collide: A Tale of Chlamydia trachomatis and Sexually Transmitted Viruses

  2023influential citation
• PD-L1 and p53 expression in squamous cell carcinoma of the oropharynx depending on human papilloma virus status

  2023cites this paper
• Full eradication of pre‐clinical human papilloma virus‐induced tumors by a lentiviral vaccine

  2023cites this paper
• Temporal composition of the cervicovaginal microbiome associates with hrHPV infection outcomes in a longitudinal study

  2023cites this paper
• Human Papillomavirus Infections and Increased Risk of Incident Osteoporosis: A Nationwide Population-Based Cohort Study

  2023cites this paper
• Global Type-Specific Genital Human Papillomavirus Prevalence in Men, by Sexual Orientation: A Systematic Review and Meta-Analysis

  2023cites this paper
• Multidimensional outlook on the pathophysiology of cervical cancer invasion and metastasis

  2023cites this paper
• Immunotherapy of Equine Sarcoids—From Early Approaches to Innovative Vaccines

  2023cites this paper
• Type-specific concurrent anogenital HPV detection among young women and MSM attending Dutch sexual health clinics

  2022cites this paper
• Buschke Lowenstein tumor (BLT)/giant condyloma acuminatum (GCA): An immunopathogenesis insight

  2022cites this paper
• Evidence of High-Risk Human Papillomavirus in Esophageal Cancer in East Azerbaijan Province, Northwest of Iran

  2022cites this paper
• An Update on Human Papilloma Virus Vaccines: History, Types, Protection, and Efficacy

  2022cites this paper
• Therapeutic DNA Vaccines against HPV-Related Malignancies: Promising Leads from Clinical Trials

  2022cites this paper
• Female Human Papillomavirus Infection Associated with Increased Risk of Ectopic Pregnancy: Early Evidence from Taiwan Population-Based Cohort Study

  2022cites this paper
• HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management

  2022cites this paper
• Human Papillomaviruses as Infectious Agents in Gynecological Cancers. Oncogenic Properties of Viral Proteins

  2022cites this paper
• Consideration of underlying immunodeficiency in refractory or recalcitrant warts: A review of the literature

  2022cites this paper
• Assessment of sinecatechins 10% ointment used as proactive sequential therapy in recurrence rate of genital warts lesions after cryotherapy. The PACT-II Trial (postablation immunomodulator treatment of condylomata with sinecatechins): a prospective assessor-blinded, multicenter, pilot trial.

  2022cites this paper
• Immunotherapeutic Approaches for the Treatment of HPV-Associated (Pre-)Cancer of the Cervix, Vulva and Penis

  2022cites this paper
• Interferon therapy of recurrent herpesvirus infections

  2022cites this paper
• Development and therapeutic manipulation of the head and neck cancer tumor environment to improve clinical outcomes

  2022cites this paper
• The Creation of the Suppressive Cancer Microenvironment in Patients with HPV-Positive Cervical Cancer

  2022cites this paper
• Can Adjuvant HPV Vaccination Be Helpful in the Prevention of Persistent/Recurrent Cervical Dysplasia after Surgical Treatment?—A Literature Review

  2022cites this paper
• Competing Endogenous RNA (ceRNA) Networks and Splicing Switches in Cervical Cancer: HPV Oncogenesis, Clinical Significance and Therapeutic Opportunities

  2022cites this paper
• The role of the human papilloma virus in the development of potentially malignant diseases and squamous cell carcinomas of the oral mucosa

  2022cites this paper
• Human Papillomavirus E1 Protein Regulates Gene Expression in Cells Involved in Immune Response

  2022cites this paper
• What do cancer-specific T cells ‘see’?

  2022cites this paper
• Human Papillomavirus Cervical Infection: Many Ways to a Single Destination

  2022cites this paper
• CD4+ and CD8+ Tumor-Infiltrating Lymphocytes (TILs) Biomarkers: Role in Predicting the Stadium and Prognosis of Cervical Cancer

  2022cites this paper
• Cytokine response following perturbation of the cervicovaginal milieu during HPV genital infection

  2021cites this paper
• Vulvar Verrucous Carcinoma and Genital Condylomatosis

  2021cites this paper
• HPV-mediated Cervical Cancer: A Systematic review on Immunological Basis, Molecular Biology and Immune evasion mechanisms.

  2021cites this paper
• The role of NFKB1/NFKBIA genetic variants in HPV infection: A cross-sectional cohort study.

  2021cites this paper
• Viral Causality of Human Cancer and Potential Roles of Human Endogenous Retroviruses in the Multi-Omics Era: An Evolutionary Epidemiology Review

  2021cites this paper
• Benefits of Gender-Neutral Vaccination Strategy for the Prevention of HPV-Associated Diseases and the Eradication of HPV Infection in General. Current State of HPV Vaccination in the World

  2021cites this paper
• Papillomaviruses: Basic General, Molecular, Clinical and Immune Evasion Mechanisms

  2021cites this paper
• Mid-treatment Fluorodeoxyglucose Positron Emission Tomography in Human Papillomavirus-related Oropharyngeal Squamous Cell Carcinoma Treated with Primary Radiotherapy: Nodal Metabolic Response Rate can Predict Treatment Outcomes.

  2021cites this paper
• CXCL10 Produced by HPV-Positive Cervical Cancer Cells Stimulates Exosomal PDL1 Expression by Fibroblasts via CXCR3 and JAK-STAT Pathways

  2021cites this paper
• Is There a Role for Sex Hormone Receptors in Head-and-neck Cancer? Links with HPV Infection and Prognosis

  2021cites this paper
• The interplay between the vaginal microbiome and innate immunity in the focus of predictive, preventive, and personalized medical approach to combat HPV-induced cervical cancer

  2021cites this paper
• Tumor Immunity and Immunotherapy for HPV-Related Cancers.

  2021cites this paper
• Pathogenic Role of Immune Evasion and Integration of Human Papillomavirus in Oropharyngeal Cancer

  2021cites this paper
• Human papillomavirus symptomatic infection associated with increased risk of new-onset alopecia areata: A nationwide population-based cohort study.

  2021cites this paper
• Association of Human Papillomavirus With Oral Lichen Planus and Oral Leukoplakia: A Meta-analysis.

  2020cites this paper
• Potential Effects of Human Papillomavirus Type Substitution, Superinfection Exclusion and Latency on the Efficacy of the Current L1 Prophylactic Vaccines

  2020cites this paper
• The Tumor Microenvironment and Immunotherapy of Oropharyngeal Squamous Cell Carcinoma

  2020cites this paper
• Regression of genital papules and mild cervical intraepithelial neoplasia during immunotherapy (clinical case)

  2020cites this paper
• The place of immunotherapy in the treatment of recurrent viral infections of the urogenital tract

  2020cites this paper
• HPV post-infection microenvironment and cervical cancer.

  2020cites this paper
• Evolving Profile of HPV-Driven Oropharyngeal Squamous Cell Carcinoma in a National Cancer Institute in Italy: A 10-Year Retrospective Study

  2020cites this paper
• Smoking: Is it a Risk Factor for Common Warts?

  2020cites this paper
• The Role of HLA-G in Human Papillomavirus Infections and Cervical Carcinogenesis

  2020cites this paper
• Biological Pathways of HPV-Induced Carcinogenesis

  2020cites this paper
• HPV Involvement in the Tumor Microenvironment and Immune Treatment in Head and Neck Squamous Cell Carcinomas

  2020cites this paper